Horizontal gene transfer mechanisms US Medical PG Practice Questions and MCQs
Practice US Medical PG questions for Horizontal gene transfer mechanisms. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Horizontal gene transfer mechanisms US Medical PG Question 1: In translation, the wobble phenomenon is best illustrated by the fact that:
- A. Charged tRNA contains energy needed for peptide bonds to form
- B. The last nucleotide provides specificity for the given amino acid
- C. A tRNA with the UUU anticodon can bind to either AAA or AAG codons (Correct Answer)
- D. There are more amino acids than possible codons
- E. The genetic code is preserved without mutations
Horizontal gene transfer mechanisms Explanation: ***A tRNA with the UUU anticodon can bind to either AAA or AAG codons***
- The **wobble phenomenon** allows for non-standard base pairing between the **first nucleotide (5' position) of the tRNA anticodon** and the **third nucleotide (3' position) of the mRNA codon**.
- In this example, a tRNA with anticodon **3'-UUU-5'** can bind to either **5'-AAA-3'** or **5'-AAG-3'** codons (both encoding lysine) due to the relaxed base-pairing rules at the wobble position.
- This flexibility means fewer tRNAs are needed to recognize all 61 sense codons, illustrating the **degeneracy of the genetic code**.
- According to Crick's wobble hypothesis, **U at the 5' position of the anticodon** can pair with either **A or G at the 3' position of the codon**.
*Charged tRNA contains energy needed for peptide bonds to form*
- While **charged tRNA** (aminoacyl-tRNA) does carry an amino acid activated for peptide bond formation, this statement describes the energy source for translation, not the wobble phenomenon.
- The energy for peptide bond formation comes from the **high-energy ester bond** linking the amino acid to the tRNA, not from the base pairing itself.
*The last nucleotide provides specificity for the given amino acid*
- The **last nucleotide** (3' position) of the mRNA codon is where **wobble pairing** occurs, meaning it does *not* always provide strict specificity for the amino acid due to the relaxed base-pairing rules.
- It is often the *first two nucleotides* of the codon that are most critical in determining the specific amino acid incorporated.
*There are more amino acids than possible codons*
- This statement is incorrect; there are **20 standard amino acids** and **61 sense codons** (three are stop codons), meaning there are more codons than amino acids, leading to **code degeneracy**.
- The concept of wobble base pairing helps explain how this degeneracy is managed efficiently, but the premise of this option is false.
*The genetic code is preserved without mutations*
- This statement refers to the **fidelity of DNA replication and repair** or the evolutionary conservation of the genetic code, not the mechanism of translation or wobble base pairing.
- The genetic code being largely universal and degenerate does not mean that mutations never occur, but rather that it is robust.
Horizontal gene transfer mechanisms US Medical PG Question 2: Part of the success of the Streptococcus pyogenes bacterium lies in its ability to evade phagocytosis. Which of the following helps in this evasion?
- A. Streptolysin S
- B. Streptolysin O
- C. Streptokinase
- D. M protein (Correct Answer)
- E. Pyrogenic toxin
Horizontal gene transfer mechanisms Explanation: ***M protein***
- The **M protein** is a major virulence factor of *Streptococcus pyogenes* that **inhibits phagocytosis** by binding to factor H, a host complement regulatory protein, preventing C3b deposition.
- It also helps the bacterium adhere to host cells and resist killing by neutrophils.
*Streptolysin S*
- **Streptolysin S** is a **hemolysin** that causes beta-hemolysis on blood agar and contributes to tissue damage by lysing cells.
- While contributing to virulence, its primary role is not direct inhibition of phagocytosis but rather cell lysis.
*Streptolysin O*
- **Streptolysin O (SLO)** is another **hemolysin** that produces pore-forming toxins, leading to cell lysis and tissue destruction.
- It is highly antigenic and often used as a diagnostic marker (ASO titer) for past *S. pyogenes* infections, but it does not directly prevent phagocytosis.
*Streptokinase*
- **Streptokinase** is an enzyme that activates plasminogen, leading to the breakdown of fibrin clots, which helps in the **spread of infection** within tissues.
- Its main function is not to evade phagocytosis but rather to facilitate invasion by dissolving blood clots that would typically wall off the infection.
*Pyrogenic toxin*
- **Pyrogenic toxins** (also known as erythrogenic toxins) are superantigens that cause symptoms like fever and rash (e.g., in scarlet fever) by stimulating a massive, non-specific T-cell activation.
- These toxins contribute to the systemic manifestations of infection but do not directly interfere with the process of phagocytosis.
Horizontal gene transfer mechanisms US Medical PG Question 3: An outbreak of diphtheria has occurred for the third time in a decade in a small village in South Africa. Diphtheria is endemic to the area with many healthy villagers colonized with different bacterial strains. Vaccine distribution in this area is difficult due to treacherous terrain. A team of doctors is sent to the region to conduct a health campaign. Toxigenic strains of C. diphtheria are isolated from symptomatic patients. Which of the following best explains the initial emergence of a pathogenic strain causing such outbreaks?
- A. Infection with a lytic phage
- B. Conjugation between the toxigenic and non-toxigenic strains of C. diphtheriae
- C. Suppression of lysogenic cycle
- D. Lysogenic conversion (Correct Answer)
- E. Presence of naked DNA in the environment
Horizontal gene transfer mechanisms Explanation: ***Lysogenic conversion***
- **Lysogenic conversion** occurs when a temperate bacteriophage infects a bacterium and integrates its DNA into the bacterial genome, carrying genes that confer new properties, such as **toxin production**.
- The **diphtheria toxin** gene is encoded by the *tox* gene carried by the **beta-phage**, which integrates into *Corynebacterium diphtheriae* via lysogeny, converting a non-pathogenic strain into a pathogenic one.
*Infection with a lytic phage*
- A **lytic phage** infects a bacterium, replicates rapidly, and then lyses the host cell, releasing new phage particles; it typically does not integrate into the host genome to confer new stable properties like toxin production.
- Lytic phages are primarily responsible for bacterial destruction, not for conferring new stable virulence factors like the **diphtheria toxin**.
*Conjugation between the toxigenic and non-toxigenic strains of C. diphtheriae*
- **Conjugation** involves the direct transfer of genetic material via a pilus between bacteria, usually involving plasmids. While it can transfer virulence factors, the **diphtheria toxin gene** is chromosomally integrated via a **phage**, not typically transferred through conjugation in this manner.
- *C. diphtheriae* toxin production is specifically associated with the presence of the **toxin gene from a lysogenic bacteriophage**, not plasmid-mediated transfer between strains.
*Suppression of lysogenic cycle*
- **Suppression of the lysogenic cycle** means the phage exits the dormant lysogenic state and enters the lytic cycle, leading to host cell lysis. This would not explain the *initial emergence* or stable acquisition of toxin production.
- If the lysogenic cycle were suppressed, the integrated phage (and thus the **toxin gene**) might be lost or the host cell destroyed, rather than stably expressing a new pathogenic trait.
*Presence of naked DNA in the environment*
- The presence of **naked DNA** in the environment leads to **transformation**, where bacteria take up free DNA from their surroundings. While this can transfer genes, the **diphtheria toxin gene** is specifically introduced into *C. diphtheriae* by a **lysogenic bacteriophage**, not typically by free environmental DNA.
- Transformation is a mechanism for acquiring genetic material, but the origin and mechanism of acquisition for the **diphtheria toxin gene** are well-established as phage-mediated.
Horizontal gene transfer mechanisms US Medical PG Question 4: An investigator is studying bacterial toxins in a nonpathogenic bacterial monoculture that has been inoculated with specific bacteriophages. These phages were previously cultured in a toxin-producing bacterial culture. After inoculation, a new toxin is isolated from the culture. Genetic sequencing shows that the bacteria have incorporated viral genetic information, including the gene for this toxin, into their genome. The described process is most likely responsible for acquired pathogenicity in which of the following bacteria?
- A. Staphylococcus aureus
- B. Haemophilus influenzae
- C. Neisseria meningitidis
- D. Streptococcus pneumoniae
- E. Corynebacterium diphtheriae (Correct Answer)
Horizontal gene transfer mechanisms Explanation: ***Corynebacterium diphtheriae***
- The process described, where a bacterium acquires new genetic information (e.g., a toxin gene) from a bacteriophage, is called **lysogenic conversion** or **phage conversion**. *Corynebacterium diphtheriae* is the **classic example** of this mechanism, acquiring its toxigenicity through phage-mediated transfer of the **diphtheria toxin gene (tox gene)** via bacteriophage β.
- The diphtheria toxin is an **AB toxin** that ADP-ribosylates and thereby inactivates **elongation factor 2 (EF-2)**, inhibiting host cell protein synthesis and leading to the characteristic symptoms of diphtheria.
- This is the **prototypical and most clinically significant example** of lysogenic conversion in medical microbiology.
*Staphylococcus aureus*
- While *Staphylococcus aureus* can acquire some virulence factors via bacteriophages (e.g., **Panton-Valentine leukocidin**, some enterotoxins), many of its toxins are encoded on **mobile genetic elements** such as plasmids, pathogenicity islands, or chromosomal genes.
- However, *S. aureus* is **not the classic example** of lysogenic conversion described in this scenario. *C. diphtheriae* better exemplifies the acquisition of a major toxin exclusively through phage conversion.
*Haemophilus influenzae*
- *Haemophilus influenzae* primarily causes disease through its **polysaccharide capsule** (especially type b) and is a common cause of respiratory infections and meningitis.
- Its major virulence factors are typically chromosomally encoded or acquired through **transformation** (uptake of naked DNA), not through phage conversion for a primary toxin.
*Neisseria meningitidis*
- *Neisseria meningitidis* causes meningococcal disease, primarily due to its **polysaccharide capsule** and **endotoxin (LPS)**.
- While genetic exchange can occur, the acquisition of a major toxin gene by phage conversion as described is not a primary mechanism for its key virulence factors.
*Streptococcus pneumoniae*
- *Streptococcus pneumoniae* is a leading cause of pneumonia, meningitis, and otitis media, with its main virulence factor being its **polysaccharide capsule**.
- It primarily acquires genetic material through **transformation** (competence-mediated uptake of naked DNA), which contributes to antibiotic resistance and capsule types, but lysogenic conversion with toxin acquisition is not typical for its major virulence factors.
Horizontal gene transfer mechanisms US Medical PG Question 5: A 35-year-old female presents to the emergency room complaining of diarrhea and dehydration. She has been experiencing severe watery diarrhea for the past 3 days. She reports that she has been unable to leave the bathroom for more than a few minutes at a time. The diarrhea is profuse and watery without visible blood or mucus. She recently returned from a volunteer trip to Yemen where she worked at an orphanage. Her past medical history is notable for psoriasis for which she takes sulfasalazine. The patient drinks socially and does not smoke. Her temperature is 99°F (37.2°C), blood pressure is 100/55 mmHg, pulse is 130/min, and respirations are 20/min. Mucous membranes are dry. Her eyes appear sunken. Capillary refill is 4 seconds. The patient is started on intravenous fluid resuscitation. Which of the following processes is capable of transmitting the genetic material for the toxin responsible for this patient's condition?
- A. Transposition
- B. Conjugation
- C. Endospore formation
- D. Transduction (Correct Answer)
- E. Transformation
Horizontal gene transfer mechanisms Explanation: ***Transduction***
- The patient's symptoms are highly suggestive of **cholera**, caused by *Vibrio cholerae*, which produces **cholera toxin**.
- The genes for cholera toxin are carried on a **bacteriophage (CTXφ)**, and their transfer between bacteria occurs via **transduction**.
*Transposition*
- **Transposition** involves the movement of **transposons ("jumping genes")** within a genome or between DNA molecules.
- While transposons can carry antimicrobial resistance genes or virulence factors, this mechanism is not typically associated with the transfer of the primary cholera toxin genes.
*Conjugation*
- **Conjugation** is the transfer of genetic material between bacteria through direct cell-to-cell contact, often involving a **pilus** and the transfer of **plasmids**.
- While *Vibrio cholerae* can engage in conjugation, the cholera toxin genes are predominantly acquired via specialized transduction with the CTXφ phage, not typically plasmid-mediated conjugation.
*Endospore formation*
- **Endospore formation** is a survival mechanism used by certain bacteria (e.g., *Clostridium*, *Bacillus*) to withstand harsh environmental conditions.
- It is not a mechanism for **horizontal gene transfer** or the transmission of toxin-encoding genetic material between bacteria.
*Transformation*
- **Transformation** is the uptake of **naked DNA** from the environment by a bacterial cell.
- While *Vibrio cholerae* can be naturally competent for transformation, the cholera toxin genes are primarily acquired through **phage-mediated transduction**, not free DNA uptake.
Horizontal gene transfer mechanisms US Medical PG Question 6: An investigator studying mechanisms of acquired antibiotic resistance in bacteria conducts a study using isolated strains of Escherichia coli and Staphylococcus aureus. The E. coli strain harbors plasmid pRK212.1, which conveys resistance to kanamycin. The S. aureus strain is susceptible to kanamycin. Both bacterial strains are mixed in a liquid growth medium containing deoxyribonuclease. After incubation for 2 days and subsequent transfer to a solid medium, the S. aureus colonies show no lysis in response to the application of kanamycin. Analysis of chromosomal DNA from the kanamycin-resistant S. aureus strain does not reveal the kanamycin-resistance gene. Which of the following mechanisms is most likely responsible for this finding?
- A. Transformation
- B. Conjugation (Correct Answer)
- C. Transduction
- D. Transposition
- E. Secretion
Horizontal gene transfer mechanisms Explanation: ***Conjugation***
- The presence of **deoxyribonuclease (DNase)** in the growth medium inhibits **transformation**, ruling out the uptake of naked DNA. The transfer of the kanamycin resistance gene from a plasmid in *E. coli* to *S. aureus* in the presence of DNase strongly points to **cell-to-cell contact** via conjugation.
- The resistance gene is found on a **plasmid** in *E. coli* and is transferred to *S. aureus*, resulting in kanamycin resistance without integrating into the *S. aureus* chromosome, which is characteristic of conjugative plasmid transfer.
- **Key experimental clue**: DNase destroys free DNA in the medium, so the only way for genetic material to transfer is through **direct cell-to-cell contact**, which is the hallmark of conjugation.
*Transformation*
- This process involves the uptake of **naked DNA** from the environment by a bacterial cell, which would have been prevented by the presence of **deoxyribonuclease** in the medium.
- Transformation typically results in the integration of the foreign DNA into the host cell's **chromosome** or stable maintenance as a plasmid, but DNase would degrade any free DNA before uptake could occur.
*Transduction*
- **Transduction** involves the transfer of genetic material via a **bacteriophage**. The scenario does not describe the presence of any phage particles, nor is there mention of viral vectors.
- The resistance gene originates from a **plasmid** in *E. coli*, and transduction would require a phage capable of infecting both species, which is not mentioned in the experimental design.
*Transposition*
- **Transposition** is the movement of a segment of DNA from one location to another within the **same cell** (e.g., between a plasmid and chromosome). It does not explain the transfer of genetic material **between** two different bacterial cells.
- While a **transposon** might carry the kanamycin resistance gene on the plasmid, transposition itself is not the mechanism for **inter-species transfer** observed in this experiment.
*Secretion*
- **Secretion** refers to the active release of molecules (proteins, enzymes, toxins) from a cell. It is not a mechanism for the direct transfer of **genetic material** (like a plasmid or gene) from one bacterium to another.
- Genetic material is transferred through conjugation, transformation, or transduction, not by secretion pathways.
Horizontal gene transfer mechanisms US Medical PG Question 7: A parent presents to her pediatrician requesting information about immunizations for her newborn. The pediatrician explains about basic principles of immunization, types of vaccines, possible adverse effects, and the immunization schedule. Regarding how immunizations work, the pediatrician explains that there are mainly 2 types of vaccines. The first type of vaccine provides stronger and more lasting immunity as it induces both cellular and humoral immune responses. The second type of vaccine produces mainly a humoral response only, and its overall efficacy is less as compared to the first type. Which of the following vaccines belongs to the first type of vaccine that the pediatrician is talking about?
- A. Hepatitis A vaccine
- B. Polio vaccine (Salk)
- C. Yellow fever vaccine (Correct Answer)
- D. Rabies vaccine
- E. Hepatitis B vaccine
Horizontal gene transfer mechanisms Explanation: ***Yellow fever vaccine***
- The Yellow fever vaccine is a **live-attenuated vaccine**, which mimics natural infection and effectively stimulates both **cellular and humoral immune responses**, leading to strong and long-lasting immunity.
- Live-attenuated vaccines contain a weakened form of the pathogen, allowing for replication within the host and robust immune system activation.
*Hepatitis A vaccine*
- The Hepatitis A vaccine is an **inactivated vaccine**, which primarily induces a **humoral (antibody-mediated) immune response**.
- Inactivated vaccines generally do not stimulate a strong cellular immune response and often require booster doses to maintain protective immunity.
*Polio vaccine (Salk)*
- The Salk polio vaccine is an **inactivated polio vaccine (IPV)**, meaning it contains killed viral particles.
- As an inactivated vaccine, it mainly elicits a **humoral immune response** producing circulating antibodies but less mucosal or cellular immunity.
*Rabies vaccine*
- The Rabies vaccine is an **inactivated vaccine** given after exposure or for pre-exposure prophylaxis.
- It primarily induces a **humoral antibody response** rather than a strong cellular immune response.
*Hepatitis B vaccine*
- The Hepatitis B vaccine is a **recombinant vaccine**, containing only a portion of the viral antigen (HBsAg).
- This type of vaccine primarily stimulates a **humoral immune response** leading to antibody production, which is effective but does not typically induce a strong cellular response like live vaccines.
Horizontal gene transfer mechanisms US Medical PG Question 8: An investigator is studying human genetics and cell division. A molecule is used to inhibit the exchange of genetic material between homologous chromosomes. Which of the following phases of the cell cycle does the molecule target?
- A. Prophase II
- B. Prophase I (Correct Answer)
- C. Metaphase II
- D. Telophase I
- E. Anaphase I
Horizontal gene transfer mechanisms Explanation: ***Prophase I***
- **Crossing over** (genetic recombination) occurs specifically during **Prophase I** of meiosis, particularly during the pachytene stage
- During this phase, homologous chromosomes pair up (synapsis) and exchange genetic material through recombination
- Inhibiting this exchange means targeting the phase where this critical genetic recombination takes place
*Prophase II*
- Prophase II is a stage in meiosis II where chromosomes condense again after a brief interkinesis
- **Crossing over does not occur** in Prophase II - genetic recombination has already been completed in Prophase I
- Homologous chromosomes are no longer paired at this stage
*Metaphase II*
- During Metaphase II, individual chromosomes (not homologous pairs) align along the metaphase plate
- There is **no exchange of genetic material** between homologous chromosomes at this stage
- This phase prepares for the separation of sister chromatids
*Telophase I*
- Telophase I involves decondensation of chromosomes and reformation of nuclear envelopes around the separated homologous chromosomes
- This marks the end of meiosis I, **after** genetic exchange has already occurred in Prophase I
- No crossing over occurs during this phase
*Anaphase I*
- In Anaphase I, **homologous chromosomes separate** and move to opposite poles of the cell
- This phase is characterized by segregation of chromosomes, **not genetic exchange**
- Crossing over has already been completed by this stage
Horizontal gene transfer mechanisms US Medical PG Question 9: A 29-year-old pregnant woman with no prior antibiotic exposure presents with gonorrhea. Culture of Neisseria gonorrhoeae shows resistance to penicillin, tetracycline, and fluoroquinolones. Genetic testing reveals she has a strain with chromosomal mutations in penA (mosaic allele), mtrR promoter, and gyrA. She reports her partner recently returned from Southeast Asia. Apply epidemiologic and resistance mechanism knowledge to determine the most appropriate management and public health action.
- A. Treat with ceftriaxone alone and report to local health department
- B. Treat with dual therapy (ceftriaxone plus azithromycin) and initiate partner notification with travel history documentation (Correct Answer)
- C. Perform cephalosporin susceptibility testing before treatment initiation
- D. Treat with azithromycin monotherapy due to pregnancy
- E. Initiate spectinomycin therapy and routine partner notification only
Horizontal gene transfer mechanisms Explanation: ***Treat with dual therapy (ceftriaxone plus azithromycin) and initiate partner notification with travel history documentation***
- The presence of the **mosaic penA allele** and **mtrR promoter mutations** signifies significant resistance potential; **dual therapy** with ceftriaxone and azithromycin remains critical for ensuring cure and slowing further resistance in highly resistant strains.
- Given the partner's travel to **Southeast Asia**, a region known for emerging **extensively drug-resistant (XDR)** gonorrhea, documenting travel and notification is vital for public health **surveillance**.
*Treat with ceftriaxone alone and report to local health department*
- While ceftriaxone is the backbone of treatment, using **monotherapy** for a strain already exhibiting multiple chromosomal resistance mutations (mosaic penA) increases the risk of selecting for **cephalosporin resistance**.
- This approach is less robust than dual therapy in the context of suspected **imported resistant strains** from high-risk geographic regions.
*Perform cephalosporin susceptibility testing before treatment initiation*
- Delaying treatment for **Neisseria gonorrhoeae** waiting for susceptibility results is inappropriate as it allows for ongoing **transmission** and potential progression to **pelvic inflammatory disease**.
- Clinical guidelines recommend **empiric treatment** based on local prevalence and travel history while simultaneously performing surveillance cultures.
*Treat with azithromycin monotherapy due to pregnancy*
- **Azithromycin monotherapy** is contraindicated for gonorrhea treatment because it has a low barrier to resistance and would fail to cover chromosomal mutations affecting **efflux pumps (mtrR)**.
- While both drugs are safe in **pregnancy**, azithromycin must be used in **combination** with ceftriaxone to prevent treatment failure.
*Initiate spectinomycin therapy and routine partner notification only*
- **Spectinomycin** is a second-line agent that is currently not readily available in the United States and has poor efficacy for **pharyngeal infections**.
- Focusing only on routine notification ignores the critical **epidemiologic significance** of the Southeast Asian travel history associated with highly resistant strains.
Horizontal gene transfer mechanisms US Medical PG Question 10: A 67-year-old woman with persistent Enterococcus faecium bacteremia despite appropriate vancomycin therapy undergoes repeat culture. The isolate now shows vancomycin MIC of 128 μg/mL (previously 2 μg/mL). PCR testing reveals the presence of vanA gene cluster. Hospital epidemiology traces potential sources. What is the most likely mechanism by which this organism acquired high-level vancomycin resistance?
- A. Spontaneous chromosomal mutation during therapy
- B. Transposon-mediated transfer from vancomycin-resistant enterococci (Correct Answer)
- C. Transformation with DNA from lysed resistant bacteria
- D. Increased vancomycin efflux pump expression
- E. Alteration in cell wall synthesis without genetic acquisition
Horizontal gene transfer mechanisms Explanation: ***Transposon-mediated transfer from vancomycin-resistant enterococci***
- High-level vancomycin resistance in Enterococcus is primarily mediated by the **vanA gene cluster**, which is carried on the **Tn1546 transposon** and spread via **conjugation**.
- This mechanism involves the replacement of the terminal **D-Ala-D-Ala** of peptidoglycan precursors with **D-Ala-D-Lac**, resulting in a 1000-fold decrease in vancomycin binding affinity.
*Spontaneous chromosomal mutation during therapy*
- While mutations can cause resistance to some antibiotics (like rifampin), **high-level vancomycin resistance** in enterococci is not caused by single-point mutations.
- A sudden jump in MIC from 2 to 128 μg/mL is characteristic of **horizontal gene transfer** rather than the gradual accumulation of chromosomal mutations.
*Transformation with DNA from lysed resistant bacteria*
- **Transformation** (uptake of naked DNA) is less common in enterococci compared to **conjugation** for the transfer of large, complex gene clusters like **vanA**.
- The epidemiological tracing implied in the scenario is classic for the spread of **plasmids** and **transposons** between colonized patients in a hospital setting.
*Increased vancomycin efflux pump expression*
- **Efflux pumps** are significant for resistance against drugs like tetracyclines or fluoroquinolones, but they are not the mechanism for **vancomycin resistance**.
- Vancomycin is a large **glycopeptide molecule**; resistance is achieved through **structural modification** of its target (cell wall precursors) rather than active expulsion.
*Alteration in cell wall synthesis without genetic acquisition*
- Vancomycin-intermediate S. aureus (**VISA**) involves cell wall thickening without new gene acquisition, but this results in a **smaller, gradual MIC increase**.
- The detection of the **vanA gene** by PCR confirms that the resistance is due to **acquired genetic material** rather than a purely metabolic or adaptive physiological change.
More Horizontal gene transfer mechanisms US Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
